Learn about the role of precision oncology in advanced melanoma treatment.

For patients with lung cancer, biomarker testing may be an option.

Research exploring the first visible changes in the brain is helping scientists evaluate new potential treatments for Alzheimer’s.

Researchers at Novartis are combining modern techniques with an old approach to drug discovery and getting surprising results.

Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.

By growing human tumors in mice, NIBR develops a unique system that seeks to mimic clinical trials of cancer drugs